Stock Analysis · Sandoz Group AG (SDZXF)
Sandoz is a pure-play generics and biosimilars company with global scale, rising revenue, and a much stronger 2025 profit profile. Its focused healthcare role and exposure to lower-cost medicines make it a compelling company to examine for long-term business durability.